Tenecteplase in Wake-up Ischaemic Stroke Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

Also called NCT03181360

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03181360
  • EudraCT 2014-000096-80
Other papers using this trial's data
  • Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial The Lancet. Neurology, 2023-02 DOI, PubMed 36549308

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Denmark, Estonia, Finland, Latvia, Lithuania, New Zealand, Norway, Sweden, Switzerland, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03181360. Randomized; single masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tenecteplase in Wake-up Ischaemic Stroke Trial
Acronym
TWIST
Condition
Stroke, Acute
Intervention (Drug)
Tenecteplase
Intervention (Other)
Control
Lead sponsor
University Hospital of North Norway (class: other)
Collaborator
UiT The Arctic University of Norway (class: other)
Collaborator
The Royal Norwegian Ministry of Health (class: other)
Collaborator
Norwegian Health Association (class: other)

Record details

Record id
cardio:ct-nct03181360
Content hash
fd837445a46cfb20ffae195f2dd82d6086feba1bccbe4bc1cfebf91f78efdd7b